ENFN Enfusion PE ratio, current and historical analysis
As of Mar 19, 2025, the ENFN stock has a PE ratio of 369.67. The calculation is based on the latest EPS of $0.03 and the stock price of $11.09 per share. An increase of 34% has been observed in the PE ratio compared to its average of 275.5 of the last four quarters.
ENFN PE ratio history
The mean historical PE ratio of Enfusion over the last two years is 219.42. The current 369.67 P/E ratio is 68% higher than the historical average. Looking back at the last two years, ENFN's PE ratio peaked in the Dec 2024 quarter at 343.33, with a price of $10.3 and an EPS of $0.03. The Sep 2023 quarter marked the lowest point at 112.13, with a price of $8.97 and an EPS of $0.08.
Enfusion PE ratio by year
Maximum annual increase: 147.77% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 343.33 | 147.77% | $10.3 | $0.03 |
| 2023 | 138.57 | N/A | $9.7 | $0.07 |
| 2022 | N/A | N/A | $9.67 | -$0.1 |
| 2021 | N/A | N/A | $20.94 | -$2.26 |
| 2020 | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A |
Enfusion PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 343.33 | 44.71% | $10.3 | $0.03 |
| Sep 2024 | 237.25 | 11.38% | $9.49 | $0.04 |
| Jun 2024 | 213 | -30.92% | $8.52 | $0.04 |
| Mar 2024 | 308.33 | 122.51% | $9.25 | $0.03 |
| Dec 2023 | 138.57 | 23.58% | $9.7 | $0.07 |
| Sep 2023 | 112.13 | -20.05% | $8.97 | $0.08 |
| Jun 2023 | 140.25 | -46.57% | $11.22 | $0.08 |
| Mar 2023 | 262.5 | N/A | $10.5 | $0.04 |
| Dec 2022 | N/A | N/A | $9.67 | -$0.1 |
| Sep 2022 | N/A | N/A | $12.34 | N/A |
| Jun 2022 | N/A | N/A | $10.21 | N/A |
| Mar 2022 | N/A | N/A | $12.72 | N/A |
| Dec 2021 | N/A | N/A | $20.94 | -$2.26 |
| Sep 2021 | N/A | N/A | N/A | N/A |
| Jun 2021 | N/A | N/A | N/A | N/A |
ENFN average PE ratio chart
The current PE ratio of ENFN is higher than its 3-year average.
ENFN PE vs peers
ENFN's PE ratio stands higher than its peer stocks MSFT and ORCL. Enfusion's current PE ratio of 369.67 is similar to the average of its peers, which is 39.21.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MSFT Microsoft Corp | 31.03 | $2.88T |
| ADBE Adobe Inc | 31.46 | $170.25B |
| ORCL Oracle Corp | 35 | $430.87B |
| CRM Salesforcecom Inc | 43.31 | $268.03B |
| INTU Intuit Inc | 55.32 | $167.65B |
| NOW ServiceNow Inc | 118.69 | $169.19B |
| WDAY Workday Inc | 126.49 | $66.62B |
| ENFN Enfusion Inc | 370.5 | $1.43B |
| TEAM Atlassian Corporation | N/A | $59.3B |
Frequently asked questions
What is Enfusion's PE ratio?
As of Mar 19, 2025, ENFN stock has a price to earnings ratio of 369.67.
What is the 3-year average PE ratio for Enfusion (ENFN)?
As an average over the last 3 years, ENFN stock has a PE ratio of 219.42.
What is the highest PE ratio for ENFN?
Within the last two years, the current PE ratio is at its peak with a value of 369.67.
How does the current PE ratio for ENFN compare to its historical average?
ENFN's current price to earnings ratio is 68% above its 2-year historical average.
Why is Enfusion's PE ratio so high?
ENFN's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is ENFN's PE ratio calculated (Enfusion PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 19, 2025), Enfusion's share price is $11.09. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.03. Therefore, Enfusion's PE ratio for today is 369.67. PE RATIO(369.67) = STOCK PRICE($11.09) / TTM EPS($0.03)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.